221 – 230 of 325
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
The importance of maintaining FVIII through levels above 1% during prophylactic treatment of hemophilia A: using license study databases to answer key medical questions
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.58-58
- Contribution to journal › Published meeting abstract
-
Mark
A review of health economic studies in hemophilia prophylaxis: a collaboration of the economics expert working group of the International Prophylaxis Study Group (IPSG)
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.133-133
- Contribution to journal › Published meeting abstract
-
Mark
VWF : RCo assays using automated systems for VWF/FVIII concentrates require adjustment of assay reagents, composition and performance parameters
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.116-116
- Contribution to journal › Published meeting abstract
-
Mark
Patients' and their family members' understanding of the genetics of type 1 von Willebrand disease.
- Contribution to journal › Letter
-
Mark
Different approaches to primary prophylaxis in boys with severe hemophilia A
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.142-142
- Contribution to journal › Published meeting abstract
-
Mark
von Willebrand disease update: diagnostic and treatment dilemmas
- Contribution to journal › Article
-
Mark
Quality of life in haemophilia carriers - preliminary results of the ESCHQoL study
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.150-150
- Contribution to journal › Published meeting abstract
-
Mark
The Swedish version of hemophilia activity list, HAL
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.74-74
- Contribution to journal › Published meeting abstract
-
Mark
Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors
- Contribution to journal › Article
-
Mark
High purity, double virus-inactivated VWF/FVIII concentrate in long term prophylaxis of von Willebrand disease - experience from prospective clinical trials and German post-licensure surveillance
(2008) XXVIIIth International Congress of the World Federation of Hemophilia, 2008 In Haemophilia 14(s2). p.12-12
- Contribution to journal › Published meeting abstract
